Background: Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. DOG1 is a sensitive and specific immunohistochemical marker for the diagnosis of GIST. To date, no study has reported the utility of DOG1 immunocytochemistry on aspirate smears. Methods: Aspirates with a cytological diagnosis of GIST were retrieved. DOG1 immunocytochemistry was performed on aspirates with adequate material. Results: 23 cases were included (11 primary, 2 recurrent, 10 metastatic). Primary tumors were most frequently located in the stomach; most metastatic tumors were in the liver. Tumor cells were arranged in cohesive clusters with high cellularity. Cells were spindled, had a low N:C ratio, and a moderate amount of cytoplasm, which was elongated and tapering. Characteristic nuclear features included elongated nuclei with blunt or tapering ends, fine chromatin, mild anisonucleosis, and longitudinal grooves. The mitotic count was low, including in metastatic tumors. DOG1 immunopositivity was noted in 57% of the cases examined. Histopathology was available in 5 cases, all diagnosed as GIST. Conclusion: Cytology is a sensitive investigative modality for the preoperative diagnosis and confirmation of metastasis of GISTs. In ambiguous cases, DOG1 immunocytochemistry can serve as a valuable adjunct. Cytologic assessment, however, cannot predict malignant potential of GISTs as even metastatic tumors display bland nuclear features.

1.
Patil DT, Rubin BP: Gastrointestinal stromal tumor: advances in diagnosis and management. Arch Pathol Lab Med 2011;135:1298-1310.
2.
West RB, Corless CL, Chen X, et al: The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol 2004;165:107-113.
3.
Fatima N, Cohen C, Siddiqui MT: DOG1 utility in diagnosing gastrointestinal stromal tumors on fine-needle aspiration. Cancer Cytopathol 2011;119:202-208.
4.
Hwang DG, Qian X, Hornick JL: DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Am J Clin Pathol 2011;135:448-453.
5.
Liegl B, Hornick JL, Corless CL, Fletcher CD: Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Am J Surg Pathol 2009;33:437-446.
6.
Gu M, Ghafari S, Nguyen PT, Lin F: Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol 2001;25:343-350.
7.
Kwon MS, Koh JS, Lee SS, Chung JH, Ahn GH: Fine needle aspiration cytology (FNAC) of gastrointestinal stromal tumor: an emphasis on diagnostic role of FNAC, cell block, and immunohistochemistry. J Korean Med Sci 2002;17:353-359.
8.
Dong Q, McKee G, Pitman M, Geisinger K, Tambouret R: Epithelioid variant of gastrointestinal stromal tumor: diagnosis by fine-needle aspiration. Diagn Cytopathol 2003;29:55-60.
9.
Lozano MD, Rodriguez J, Algarra SM, et al: Fine-needle aspiration cytology and immunocytochemistry in the diagnosis of 24 gastrointestinal stromal tumors: a quick, reliable diagnostic method. Diagn Cytopathol 2003;28:131-135.
10.
Stelow EB, Stanley MW, Mallery S, et al: Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. Am J Clin Pathol 2003;119:703-708.
11.
Tamiolakis DJ, Venizelos ID, Cheva AD, et al: Fine needle aspiration cytology diagnosis of gastrointestinal stromal tumors utilizing scanning electron microscopy. Medicina (Kaunas) 2005;41:117-122.
12.
Chatzipantelis P, Salla C, Karoumpalis I, et al: Endoscopic ultrasound-guided fine needle aspiration biopsy in the diagnosis of gastrointestinal stromal tumors of the stomach. A study of 17 cases. J Gastrointestin Liver Dis 2008;17:15-20.
13.
Kaur G, Manucha V, Verma K: Gastrointestinal stromal tumors: cytomorphologic spectrum in fine needle aspiration smears. Indian J Pathol Microbiol 2010;53:271-275.
14.
Espinosa I, Lee CH, Kim MK, et al: A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol 2008;32:210-218.
15.
Hwang DG, Qian X, Hornick JL: DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Am J Clin Pathol 2011;135:448-453.
16.
Miettinen M, Wang ZF, Lasota J: DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1,840 cases. Am J Surg Pathol 2009;33:1401-1408.
17.
Lee CH, Liang CW, Espinosa I: The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology - the GIST of it. Adv Anat Pathol 2010;17:222-232.
18.
Simon S, Grabellus F, Ferrera L, et al: DOG1 regulates growth and IGFBP-5 in gastrointestinal stromal tumors. Cancer Res 2013;73:3661-3670.
19.
Vij M, Agrawal V, Kumar A, Pandey R: Cytomorphology of gastrointestinal stromal tumors and extra-gastrointestinal stromal tumors: a comprehensive morphologic study. J Cytol 2013;30:8-12.
20.
Moon JS: Endoscopic ultrasound-guided fine needle aspiration in submucosal lesion. Clin Endosc 2012;45:117-123.
21.
Cheuk W, Lee KC, Chan JK: c-kit immunocytochemical staining in the cytologic diagnosis of metastatic gastrointestinal stromal tumor. A report of two cases. Acta Cytol 2000;44:679-685.
22.
Seidal T, Edvardsson H: Diagnosis of gastrointestinal stromal tumor by fine-needle aspiration biopsy: a cytological and immunocytochemical study. Diagn Cytopathol 2000;23:397-401.
23.
Ghosh R, Mallik SR, Mathur SR, Iyer VK: CD 99 immunocytochemistry in solid pseudopapillary tumor of pancreas: a study on fine-needle aspiration cytology smears. J Cytol 2013;30:151-155.
24.
Dematteo RP, Gold JS, Saran L, et al: Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 2008;112:608-615.
25.
Elliott DD, Fanning CV, Caraway NP: The utility of fine-needle aspiration in the diagnosis of gastrointestinal stromal tumors: a cytomorphologic and immunohistochemical analysis with emphasis on malignant tumors. Cancer 2006;108:49-55.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.